Effectivity and Safety after Intravitreal Triamcinolone Acetonide and Bevacizumab Injection in Open Globe Injury
Journal: Journal of Medicinal and Chemical Sciences (Vol.6, No. 12)Publication Date: 2023-12-01
Authors : Evelyn Komaratih; Clarisa Finanda; Wimbo Sasono; Nurwasis Nurwasis; Citra Dewi Maharani; Kautsar Abiyoga; Djoko Legowo; Hari Basuki Notobroto; Willy Sandhika;
Page : 3121-3134
Keywords : Open globe injury Proliferative vitreoretinopathy Triamcinolone acetonide Bevacizumab Good health Well; being;
- The Ethanolic Extract of Basic Leaves (Ocimum basilicum) Effect on Expression of Follicle Stimulating Hormone Receptors (FSHr) and Folliculogenesis in Female Mice Model Endometriosis
- Impact of Ethanol Extract of Basil Leaves (Ocimum basilicum L.) on Mast Cell Reduction and Prostaglandin E2 Levels in Female Mice as a Model for Endometriosis Development
- Respons Superovulasi Sapi Peranakan Ongole terhadap Penyuntikan Tunggal Follicle Stimulating Hormone ke dalam Ruang Epidural (SUPEROVULATION RESPONSES IN ONGOLE CATTLE CROSSBREED TREATED WITH A SINGLE EPIDURAL INJECTION OF FOLLICLE STIMULATING HORMONE)
- A STUDY TO CORRELATE SERUM ANTI MULLERIAN HORMONE, BASAL FOLLICLE STIMULATING HORMONE AND ANTRAL FOLLICLE COUNT IN PRIMARY INFERTILITY AS A MEASURE OF OVARIAN RESERVE
- Effect of alcohol consumption on testosterone, luteinizing hormone and follicle stimulating hormone levels in males residing in Nnewi Metropolis, Anambra state, Nigeria
Abstract
Patients with open globe injury (OGI) are higher risk of developing secondary retinal detachment. This study examines the effectiveness and safety of a single intravitreal of triamcinolone acetonide or bevacizumab to suppress the expression of VEGF and TNF-α in OGI rabbit eye. OGI is generated by inflicting a 5-mm posterior ocular lesion with blade no. 11 and 6-mm inferior the limbus in the supratemporal quadrant. Intravitreal injection with triamcinolone acetonide (TA) 4 mg/0.1 mL or bevacizumab 1.25 mg/50 µL 3 days (T+3 and B+3 groups) and 7 days (T+7 and B+7 groups) after OGI (n = 6). Another OGI group without treatment served as the positive control (CtrP) while five left eyes were randomly selected from the treated group to serve as the negative control (CtrN). Pretreatment and decapitation, a comprehensive anterior segment, posterior segment, and intraocular pressure (IOP) examination was conducted on days 3, 7, and 21. On day 21, the eyes were enucleated, and VEGF and TNF-α expression were assessed by immunohistochemistry. VEGF and TNF-α overexpression were observed in rabbit eyes after OGI (9.64 ± 1,646, p = 0.0002 and 10.44 ± 1,381, and p = 0.0553, respectively). Treatments significantly reduced these pro-inflammatory proteins compared with eyes in the OGI group. Posthoc Tukey’s multiple comparison test showed that TA gave better downregulation than that of bevacizumab. Clinical examination found no significant rise of IOP at the end of the study. The current study exhibits TA intravitreal injection after OGI significantly attenuated the overexpression of pro-inflammatory protein with a good safety profile.
Other Latest Articles
- A Comparative Study of Treatment of Hypericum perforatum and Vitamin B6 for Mastalgi: Clinical Trial
- QSAR Modeling, Molecular Docking, and ADME Studies of Novel 5-Oxo- Imidazoline Derivatives as Anti-Breast Cancer Drug Compounds against MCF-7 Cell Line
- Formulation of Aromatherapy Massage Oil from Lavender (Lavandula Angustifolia), Chamomile (Matricaria Recutita), and Petitgrain (Citrus Aurantium) for Stress Relief
- Improvement of Severe Maternal Covid-19 Outcome with the Use of EMCO (Extracorporeal Membrane Oxygenation) at Dr. Soetomo General Hospital Surabaya: Serial Case Study
- An Overview and Comparison of Regulatory Pathways and Guidelines for Pediatric Study Plans in the US and EU
Last modified: 2023-09-18 16:36:25